日本皮膚科学会アトピー性皮膚炎診療ガイドライン

書誌事項

タイトル別名
  • Guideline for Management of Atopic Dermatitis
  • 日本皮膚科学会ガイドライン 日本皮膚科学会アトピー性皮膚炎診療ガイドライン
  • ニホン ヒフカ ガッカイ ガイドライン ニホン ヒフカ ガッカイ アトピーセイ ヒフエン シンリョウ ガイドライン

この論文をさがす

抄録

Standard guideline for management (diagnosis, severity scoring and therapy) of atopic dermatitis (AD) is established. In this guideline, the necessity of dermatological training is emphasized in order to assure the diagnostic skill and to evaluate the severity of AD. The present standard therapies for AD consist of the use of topical steroids and tacrolimus ointment for inflammation as well as emollients for dry and barrier-disrupted skin as the first-line topical applications, systemic anti-histamines and anti-allergic drugs for pruritus, avoidance of apparent exacerbating factors, psychological counseling, and advice about daily life. Tacrolimus ointment (0.1%) and its low density ointment (0.03%) are available for adult patients and 2–15 years old patients, respectively. The importance of suitable selection of topical steroids according to the severity of the lesion is also emphasized.

収録刊行物

被引用文献 (24)*注記

もっと見る

参考文献 (49)*注記

もっと見る

詳細情報

問題の指摘

ページトップへ